Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.5 CAD | +4.17% | +6.84% | +127.27% |
Apr. 22 | HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target | MT |
Apr. 01 | Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Elsley
FOU | Founder | - | 17-01-18 |
Director of Finance/CFO | - | 18-08-15 | |
Kelly Narine
CTO | Chief Tech/Sci/R&D Officer | - | 20-09-30 |
Andrew Hamer
CTO | Chief Tech/Sci/R&D Officer | 62 | 21-03-28 |
Bernard Lim
COO | Chief Operating Officer | - | 20-12-02 |
Trevor Burns
IRC | Investor Relations Contact | - | 16-12-31 |
John Geddes
PRN | Corporate Officer/Principal | - | 21-12-31 |
Corporate Officer/Principal | - | 15-05-31 | |
Thomas Moffatt
PRN | Corporate Officer/Principal | - | 19-02-28 |
Anne Tomalin
LAW | General Counsel | - | 21-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Elsley
FOU | Founder | - | 17-01-18 |
Jennifer Chao
BRD | Director/Board Member | 54 | 22-03-14 |
Michael Willner
BRD | Director/Board Member | 57 | 21-09-06 |
Director of Finance/CFO | - | 18-08-15 | |
Peter Pekos
BRD | Director/Board Member | - | 17-12-14 |
Chairman | - | 18-08-19 | |
Teri Loxam
BRD | Director/Board Member | 51 | 22-05-18 |
Colin Stott
BRD | Director/Board Member | 57 | 19-12-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 68,283,708 | 65,164,533 ( 95.43 %) | 0 | 95.43 % |
Company contact information
Cardiol Therapeutics, Inc.
2265 Upper Middle Road East Suite 602
L6H 0G5, Oakville
+289-910-0850
http://www.cardiolrx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+127.27% | 125M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- CRDL Stock
- Company Cardiol Therapeutics Inc.